Results 11 to 20 of about 37,412,989 (241)
Physiologically based pharmacokinetic (PBPK) model of chlorzoxazone
This repository provides the chlorzoxazone physiologically based pharmacokinetic (PBPK) model. If you have any questions or problems please open an issue FundingJan Grzegorzewski and Matthias König were supported by the Federal Ministry of Education and ...
Küttner, Jonas, König, Matthias
core +3 more sources
Pharmacokinetic (PK) modeling is a useful method for investigating drug absorption, distribution, metabolism, and excretion. The most commonly used mathematical models in PK modeling are the compartment model and physiologically based pharmacokinetic ...
Hyo-jeong Ryu +7 more
doaj +1 more source
Physiologically Based Pharmacokinetic Modeling of Nanoparticles [PDF]
Nanoparticles are frequently designed to improve the pharmacokinetics profiles and tissue distribution of small molecules to prolong their systemic circulation, target specific tissue, or widen the therapeutic window. The multifunctionality of nanoparticles is frequently presented as an advantage but also results in distinct and complicated in vivo ...
Dongfen, Yuan +4 more
openaire +2 more sources
Physiologically Based Pharmacokinetic (PBPK) Models for Ethanol [PDF]
Physiologically based pharmacokinetic models have been used to describe the distribution and elimination of ethanol after intravenous administration. These models have been used to estimate the ethanol infusion profile that is sufficient for achieving a prescribed breath ethanol concentration time course in individuals, providing a useful platform for ...
Martin H. Plawecki +4 more
openaire +3 more sources
Malnutrition in children is a global health problem, particularly in developing countries. The effects of an insufficient supply of nutrients on body composition and physiological functions may have implications for drug disposition and ultimately affect
Erik Sjögren +3 more
doaj +1 more source
Physiologically based pharmacokinetic (PBPK) model of talinolol
<p>This repository provides the talinolol physiologically based pharmacokinetic (PBPK) model.</p> <p>If you have any questions or problems please <a href="https://github.com/matthiaskoenig/talinolol-model/issues">open an issue</
Stemmer Mallol, Beatrice Amelie +1 more
core +2 more sources
Acute kidney injury (AKI) and chronic kidney disease (CKD) have become public health problems due to high morbidity and mortality. Currently, drugs recommended for patients with AKI or CKD are extremely limited, and candidates based on a new mechanism ...
Man Su +8 more
doaj +1 more source
Objective: Chronic kidney disease (CKD) has significant effects on renal clearance of drugs. The application of antibiotics in CKD patients to achieve the desired therapeutic effect is challenging.
Guoliang Deng +11 more
doaj +1 more source
Physiologically Based Pharmacokinetic Modeling of Extracellular Vesicles
Extracellular vesicles (EVs) are lipid membrane bound-cell-derived structures that are a key player in intercellular communication and facilitate numerous cellular functions such as tumor growth, metastasis, immunosuppression, and angiogenesis. They can be used as a drug delivery platform because they can protect drugs from degradation and target ...
Prashant Kumar +2 more
openaire +3 more sources
Blood biomarkers of neurological diseases are often employed to rule out or confirm the presence of significant intracranial or cerebrovascular pathology or for the differential diagnosis of conditions with similar presentations (e.g., hemorrhagic vs ...
Robert Murcko +3 more
doaj +1 more source

